ArticleFrontiers in oncology2026
Diagnostic value of high-frequency ultrasound in preoperative evaluation of benign and malignant skin tumors.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop a High-frequency ultrasound (HFUS)-based predictive nomogram integrating clinical and ultrasound features for distinguishing malignant from benign skin tumors. Methods: This retrospective study enrolled 185 patients who underwent preoperative HFUS examination for skin tumors. Patients were randomly divided into training (n=130; 73 malignant, 57 benign) and validation (n=55; 31 malignant, 24 benign) cohorts. Clinical characteristics and ultrasound features were systematically analyzed. Univariate and multivariate logistic regression analyses were used to identify independent predictors of malignancy, which were incorporated into a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results: Malignant tumors demonstrated significantly greater multilayer involvement, irregular margins, heterogeneous echogenicity, raised surface morphology, and abundant intralesional vascularity compared to benign tumors (all P<0.001). Multivariate analysis identified five independent predictors of malignancy: advanced age (OR = 1.01, 95% CI: 1.00 - 1.01), multilayer involvement (OR = 1.19, 95% CI: 1.12 - 1.26), unclear margins (OR = 1.36, 95% CI: 1.21 - 1.54), raised surface morphology (OR = 1.10, 95% CI: 1.01 - 1.21), and heterogeneous echogenicity (OR = 1.09, 95% CI: 0.99 - 1.21). The nomogram achieved area under the curve (AUC) values of 0.98 (95% CI 0.95-1.00) in the training cohort and 0.98 (95% CI 0.95-1.00) in the validation cohort. Conclusions: HFUS provides valuable information for preoperative evaluation of skin tumors. The nomogram demonstrates good diagnostic performance and clinical utility for distinguishing malignant from benign skin tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.